semaj83/ctmatch_classification huggingface dataset:
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 13.0-999.0,  HIV Infections Note: The pharmacokinetics testing portion of this study has been discontinued in Version 2.0 of this protocol. for Mothers HIV infected Between the 12th and 30th week of pregnancy Intend to continue pregnancy Viral load less than 55,000 copies/ml within 30 days of study entry CD4 count greater than 350 cells/ml within 30 days of study entry Have not previously taken anti-HIV medications (women who have taken 8 weeks or fewer of zidovudine are still eligible) OR have taken anti-HIV medication but have been off treatment for more than 180 days Intend to stop taking anti-HIV medications after pregnancy Willing to have her infant tested for HIV Parent or guardian willing to provide informed consent, if applicable  for Mothers Chemotherapy for active cancer Active opportunistic infection or severe medical condition within 14 days of study entry Chronic diarrhea within 1 month of study entry or unresolved acute diarrhea within 7 days of study entry Certain abnormal laboratory values Diabetes mellitus when not pregnant. Participants who have gestational diabetes are not excluded Current alcohol or other substance abuse that, in the opinion of the investigator, may interfere with the study Acute hepatitis within 90 days of study entry Major birth defects in infant Severe skin disorder (e.g., eczema or psoriasis) requiring systemic treatment
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Asthma Asthma symptoms brought on by allergies  Patient has any lung disease Currently have a sinus infection or cold symptoms
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  HIV Infections HIV viral load of more than 1000 copies/ml On stable antiretroviral therapy Have multidrug resistance  Require immunomodulatory drugs
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.5-17.0,  Influenza Informed consent from parent/guardian and assent from participants, when applicable, must have been obtained and signed freely Between the ages of 6 months and 17 years Three months have elapsed since liver transplantation Recipient of a liver transplant or live with a sibling who is the recipient of a liver transplant Must have the ability to comply with the study procedures for the entire length of the study  Previous immunization with an influenza vaccine for the 2004-2005 or 2005-2006 influenza season Known hypersensitivity reaction to the vaccine or vaccine component including eggs or gelatin History of Guillian-Barré syndrome Receipt of an immunoglobulin product (including intravenous or intramuscular immunoglobulin preparations, cytomegalovirus hyperimmunoglobulin and varicella-zoster immunoglobulin) within 3 months of vaccination Receipt of any live viral vaccines within 4 weeks or an inactivated viral vaccine within 2 weeks of enrollment Subjects who have experienced an acute febrile illness within the preceding 48 hours will have immunization deferred and be rescheduled once their fever has resolved
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 20.0-90.0,  Menopause Hypertension Premenopausal women: no reported change in menstrual cycle pattern Early peri-menopausal women: reported change in menstrual cycle frequency in preceding year with a bleed in the preceding 3 months Late peri-menopausal women: no menses in the preceding 3-11 months Postmenopausal women: no menses in the preceding 12 months Patients who received oophorectomy Patients who received hysterectomy for benign uterus tumor Patients underwent assisted reproductive technology (ART)  Patients underwent chemotherapy or radiotherapy in past two years
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 5.0-9.0,  Influenza Healthy children aged 5-9 years of age Parents willing to sign informed consent Availability for follow-up for the planned duration of the study at least 4 weeks after last immunization Acceptable medical history by screening evaluation and brief clinical assessment  History of immunodeficiency Known or suspected impairment of immunologic function including, but not limited to, clinically significant liver disease; diabetes mellitus; moderate to severe kidney impairment Household contact with immunodeficiency due to disease, medication or radiation Child receiving aspirin therapy or aspirin-containing therapy History of Guillain-Barré syndrome Malignancy, other than squamous cell or basal cell skin cancer Autoimmune disease History of asthma or reactive airways disease Chronic cardiovascular and pulmonary disorder Chronic metabolic diseases (including diabetes), renal dysfunction or hemoglobinopathies requiring regular medical follow-up or hospitalization during the preceding year
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Influenza The subject is a part-time or full-time employee at a major corporation. 2. The subject is eighteen years of age or older. 3. The subject is comfortable reading and writing in English. 4. The subject has reliable internet access at home, at school, or at work. 5. The subject uses email regularly (i.e. at least once every 2 days) 6. The subject does not have a known allergy to chicken eggs or a history of a severe reaction to an influenza vaccination in the past
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 20.0-50.0,  Mental Competency Mental Fatigue Healthy male and female subjects in regular employment, aged between 20 and 50 y ears. Subjects who give written informed consent in accordance with GCP and local legi slation  Subjects who present with clinical depression. Subjects showing evidence of dementia. Clinically relevant abnormalities in medical history or examination. Subjects who have participated in a clinical study within 3 months prior to the start of the study. History of drug and/or alcohol abuse. Subjects who smoke more than 10 cigarettes per day. Subjects who in the opinion of the Investigator are heavy users of other tobacco or nicotine products (e.g. snuff, chewing tobacco, nicotine patches, nicotine g um, etc.). Subjects who have a history of food and/or drug allergies relevant to the study compound. Clinically relevant deviation from normal of any finding during pre-study medica l screening. Subjects who are unable to perform the cognitive tests. Subjects currently taking a cognition enhancing substance, including any Ginkgo, ginseng or guarana product. Any subject regularly taking a medication who might stop doing so at some time d uring the active dosing phase. Pregnant or lactating women or female subjects of child-bearing potential not us ing adequate means of birth control (condoms, contraceptive pills, IUDs, sterili sation). Subjects already taking other multi-vitamin products during the last 2 weeks. Healthy subjects who are regularly taking drugs which act on the Central Nervous System (CNS)
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Head and Neck Cancer Patients must have documented advanced, locally recurrent, or metastatic head and neck carcinoma, which is untreatable by surgical resection or radiation therapy Prior chemotherapy for advanced/metastatic disease is allowed (1 regimen only) Patients must be taxane-naïve (no prior docetaxel or paclitaxel) Patients who have received chemoradiation as a primary therapy for advanced head and neck cancer are eligible Patients must have measurable or evaluable disease. Pre-study imaging for disease assessment must be done within 28 days of registration Patients with brain metastases are eligible if they have been stable for at least six weeks post-radiation therapy Aged 18 years or older Performance status of 0-2 by Zubrod criteria Life expectancy of at least 12 weeks Hematologic: absolute neutrophil count (ANC) equal to or > 1,500/mm3; hemoglobin equal to or > 8.0 g/dl; platelets equal to or > 100,000/mm3  Patients with congestive heart failure, second or third degree heart block or recent myocardial infarction within 12 months from registration are not eligible Peripheral neuropathy equal to or greater than grade 2 Patients with a history of severe hypersensitivity reaction to drugs formulated with polysorbate 80 Use of standard chemotherapy or investigational agents for treatment of head and neck cancer within 28 days of 1st dose of study drug Any medical or psychiatric illness which, in the opinion of the principal investigator, would compromise the patient's ability to tolerate this treatment regimen Prior unanticipated severe reaction to fluoropyrimidine therapy or known hypersensitivity to 5-fluorouracil Pregnant or lactating women, women of childbearing potential with either a positive pregnancy test (PPT) at baseline, or sexually active females not using a reliable contraceptive method while on study and for at least six months after chemotherapy. (Postmenopausal women must have been amenorrheic for at least 12 months to be considered of non-childbearing potential.) Sexually active patients not using a reliable contraceptive method while on study and for at least six months after chemotherapy Patients with malabsorption syndromes will be excluded. Administration of capecitabine through feeding tubes is permitted Serious concurrent infections
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-90.0,  HIV Infections Substance-Related Disorders HIV infected CD4 count greater than 350 cells/mm3 Identified from the Infectious Disease Care Clinic Body mass index greater than 18 for women and greater than 18.5 for men  Current AIDS-defining condition Currently participating in another clinical trial Pregnant or intends to become pregnant during the study
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-64.0,  Influenza Subject is healthy, as determined by medical history 2. Over 18 years of age and not yet 65 years old 3. Provides written informed consent 4. Able to attend all scheduled visits and to comply with all trial procedures 5. Women may be menopausal of 1 year or more or sugically sterile. Women of child-bearing potential must agree to be abstinent or to use a licensed form of barrier or hormonal contraception for the entire study period, and have a negative pregnancy test within 24 hours prior to vaccination  Breast-feeding 2. Receipt of an investigational drug, biologic or device in the 4 weeks preceding the trial vaccination 3. Planned participation in another clinical trial during the present trial period 4. History of Guillain-Barré Syndrome 5. Congenital or acquired immunodeficiency, immunosuppressive therapy such as anti-cancer chemotherapy or radiation therapy within the preceding 6 months, or long-term systemic corticosteroid therapy 6. Hypersensitivity to any of the vaccine components (including eggs or egg products or thimerosol and gelatin) or history of a life-threatening reaction to the trial vaccine or a vaccine containing the same substances 7. Chronic illness that could interfere with trial conduct or completion 8. Blood or blood-derived products received in the past 3 months 9. Has received any inactivated vaccine within 2 weeks or live vaccine within 4 weeks prior to enrollment into this study 10. Vaccination planned within the 4 weeks following the trial vaccination 11. Known current HIV, hepatitis B (HBsAg) or hepatitis C infection or seropositivity 12. Prior vaccination against influenza within the past 6 months 13. Allergy shot in the 7-day period prior to enrollment and must not be scheduled to receive any allergy shots in the 7-day period after enrollment 14. On coumadin or heparin therapy or has known thrombocytopenia or bleeding disorder contraindicating vaccination 15. Subject deprived of freedom by an administrative or court order, or in an emergency setting, or hospitalized without his/her consent 16. Febrile illness temperature >= 37.5°C on Day 0, prior to enrollment and vaccination 17. Any condition, that, in the opinion of the investigator, would pose a health risk to the participant 18. History of alcohol or drug abuse in the last 5 years 19. Planned travel outside the US between vaccination and the second study visit 20. Presence of any active skin disease at the injection site that, in the opinion of the Investigator, would impact vaccine delivery or assessment of vaccination site
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 60.0-999.0,  Influenza who are aged at least 60 years or older at the time of enrollment who are determined by medical history, physical examination and clinical judgement to be eligible for this study who have provided written informed consent after the nature of the study has been explained who will be available for duration of the trial (from enrollment to November 30th, 2003) who can be reached by study staff for the post-vaccination and weekly surveillance contacts [telephone, clinic or home visit]  who are perceived to be unavailable or difficult to contact for evaluation or study visits during the study period who are a resident of a nursing home or long-term care facility or other institution receiving skilled or semi-skilled nursing care (refer to Influenza study specific manual). An ambulatory subject who is a resident of a retirement home or village is eligible for the trial with any signs of renal insufficiency requiring supportive therapy or progressive neurological disease. (Subjects with other stable pre-existing disease, defined as disease not requiring change in therapy or hospitalization within 12 weeks before receipt of study vaccination will be eligible) with evidence of dementia or other severe cognitive impairment based on Mini Mental State Examination (MMSE) scores (refer to Influenza study specific manual) with a known or suspected disease of the immune system or those receiving immunosuppressive therapy, including systemic corticosteroids; or cytotoxic agents who received any blood products, including immunoglobulin, in the period from six months prior to vaccination through to the conclusion of the study have an immunosuppressed or an immunocompromised individual living in the same household with a documented history of hypersensitivity to egg or egg protein or any other component of the CAIV-T or TIV vaccine who were administered any live virus vaccine within one month prior to vaccination or expected to receive another live virus vaccine within one month of vaccination in this study for whom there is intent to administer any other investigational vaccine or agent from one month prior to enrollment through to the conclusion of the study
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  HIV Infections HIV-positive pregnant women who are between 12 and 27 weeks gestation who intend to stay in Dar es Salaam until delivery
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Perennial Allergic Rhinitis Have a documented history of allergy to perennial allergens and demonstrated sensitivity by the results of prick or intradermal skin testing Have a self-reported history of at least mild, intermittent rhinorrhea and nasal blockage/stuffiness due to allergies Have not started or had a change in immunotherapy regimen  Have a physical obstruction in the nose Will likely have an acute increase in severity of allergic rhinitis due to seasonal aeroallergens during the trial Have acute or chronic sinusitis or had previous sinus surgery resulting in a significant change in the sinus or nasal anatomy Have rhinitis medicamentosa or any other acute or chronic condition that could confound evaluations of nasal symptoms Have asthma of sufficient severity to require use of excluded medications Have taken any medications excluded as listed in the protocol Have a clinically significant acute or chronic disease or clinically significant laboratory abnormality Are a current smoker, recent smoker or past smoker as defined in the protocol
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-49.0,  Influenza Good health by history and physical exam Reliable access to a telephone Study comprehension and informed consent  Systolic BP >/= 140; diastolic BP >/= 90 Uncontrolled medical or psychiatric illness (change in last 3 months) Cancer, or treatment for cancer within 3 years Cardio-pulmonary disease requiring chronic treatment Insulin dependent diabetes mellitus Renal dysfunction (creatinine >/= 1.7 mg/dL) Hemoglobinopathies Clotting disorders that increase the risk of IM injections Immunosuppressive illnesses or drugs History of demyelinating disease (esp. Guillian-Barre syndrome)
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Kidney Transplant Recipients Participants with elevated homocysteine levels that are between the ages of 35-75 years old and have had a kidney transplant with stable renal graft function